Purchase Order SPE2DP26P0280
- Not listed
- This is a firm-fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to SZY Holdings, LLC, a for-profit limited liability company that manufactures and supplies a wide range of medical equipment, supplies, and consumables to the U.S. federal government. The contract, valued at $1,746.00, is for the delivery of moxifloxacin hydrochloride, a pharmaceutical product, with a performance period ending on April 30, 2024. The contract does not...
- This is a firm-fixed-price purchase order awarded by the Defense Logistics Agency's Medical Supply Chain division to SZY Holdings, LLC, a for-profit limited liability company based in Brooklyn, New York. The contract, valued at $2,902.62, is for the delivery of MOXIFLOXACIN HYDROC (8510390403), a pharmaceutical product, with a completion date of February 20, 2024. SZY Holdings is a manufacturer of medical equipment, supplies, and consumables, primarily serving federal government agencies. The...
- The Defense Logistics Agency Troop Support Medical awarded a $74,000 firm fixed price purchase order to SZY Holdings LLC of Brooklyn, New York for the delivery of moxifloxacin hydrochloride. Under contract number 8510026677, SZY Holdings will supply this pharmaceutical to the Defense Logistics Agency between July 20 and August 9, 2023. As a component of the Department of Defense, the Defense Logistics Agency supports America's armed forces by delivering critical supplies, equipment, and services...
- The Defense Logistics Agency Troop Support Medical awarded a $148,600 firm fixed price purchase order to SZY Holdings LLC of Brooklyn, New York. Under the contract, SZY Holdings will supply 8509986473 moxifloxacin hydrochloride to the agency through July 19, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, procuring food, fuel, repair parts and medical supplies in support of military readiness. This small business set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded SZY Holdings, LLC a $1,879.06 firm fixed-price purchase order for Ciprofloxacin tablets on July 29, 2025. This contract contains no set-aside designation and is scheduled for ultimate completion by October 6, 2025. SZY Holdings, a Brooklyn, New York-based manufacturer of medical equipment and supplies registered in the System for Award Management since 2006, will perform the work at its facility in Brooklyn. The company...
- The U.S. Department of Defense Medical Supply Chain awarded a firm fixed-price purchase order valued at $1,212.07 to SZY Holdings, LLC for the supply of Ciprofloxacin tablets. The contract, issued on September 8, 2025, with an ultimate completion date of November 17, 2025, represents a standard procurement with no set-aside designation. SZY Holdings, a Brooklyn, New York-based medical equipment and supplies manufacturer, will perform the work at its facility in Brooklyn. The company is...
- This purchase order was awarded by the Defense Logistics Agency Troop Support Medical (DLA) to SZY Holdings LLC for the delivery of levofloxacin tablets. The firm fixed price contract, valued at $83,840, calls for SZY Holdings to supply 851,0102327 units of the antibiotic medication to the DLA from its place of performance in Brooklyn, New York. No major subcontractors or set aside designations were indicated. The DLA manages the global supply chain for the Department of Defense and supports its...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain division awarded a $1,840 firm fixed-price purchase order to SZY Holdings, LLC for Nirmatrelvir and Ritonavir (an antiviral pharmaceutical treatment) on March 12, 2025. The contract, which carries no set-aside designation, is scheduled for completion by May 20, 2025, with performance taking place at the vendor's facility in Brooklyn, New York. SZY Holdings, a for-profit limited liability company and registered small business, will...
- This purchase order from the Defense Logistics Agency Troop Support Medical (DLA) awards SZY Holdings LLC $123,000 to supply ciprofloxacin hydrochloride from July 10-31, 2023. As a prime contractor, SZY Holdings will deliver the requested pharmaceutical to the agency from its Brooklyn location on a firm fixed price basis. No additional subcontractors or details regarding the product's intended use were provided. The award utilizes standard procurement procedures to fulfill DLA's mission of...
- <p>The Defense Logistics Agency Troop Support Medical awarded a $273 firm fixed price purchase order to SZY Holdings LLC of Brooklyn, NY on October 4, 2023 for the delivery of 8510191088 MEFLOQUINE HYDROCHL. The purchase order has a completion date of October 24, 2023 and does not have a set-aside designation. SZY Holdings LLC will deliver the requested pharmaceutical product to support the Defense Logistics Agency's medical supply chain mission.</p>
The Defense Logistics Agency Medical Supply Chain division awarded a purchase order to SZY Holdings, LLC for moxifloxacin, a fluoroquinolone antibiotic commonly used in military medical operations, with a firm fixed-price contract ceiling of $3,245.94. The award was issued on February 3, 2026, with an ultimate completion date of April 9, 2026. This purchase order represents an open competitive procurement with no set-aside designation. SZY Holdings, a Brooklyn, New York-based small business manufacturer, serves as the prime contractor, operating without identified subcontractors on this engagement. SZY Holdings has established itself as a reliable federal medical supply provider to the Defense Logistics Agency across multiple divisions since its registration with the System for Award Management in April 2006. The company's extensive contract portfolio demonstrates substantial experience fulfilling pharmaceutical and medical consumables requirements for U.S. military health programs, with prior awards ranging from under fifty dollars to nearly forty thousand dollars across diverse product categories including surgical equipment, diagnostic tools, and specialized medical devices. This moxifloxacin purchase order aligns with SZY Holdings' core business focus on supplying pharmaceuticals and medical products that support operational readiness and healthcare delivery within the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 2/2/26 |